For example, in the case of Leber’s congenital amaurosis (LCA) caused by RPE65 deficiency, early studies using AAV vector therapy improved visual function in some patients, but the duration of efficacy was limited by the progression of retinal degeneration. This evidence concerns the gene RPE65 and Leber congenital amaurosis.